Skip to content

Search Results

No Matching Results

    Recently Viewed


      HomeLung cancer awareness

      United to change the trajectory of lung cancer

      At Johnson & Johnson, we collaborate across our Pharmaceutical and MedTech teams and with strategic partners to unleash the full potential of lung cancer science to help change the trajectory of this complex disease.
      127200133-01 LCAM_v3_1103.mp4

      “Our goal is to prevent lung cancer from happening in the first place”

      Artificial intelligence-enabled mobile screening units. Nasal swab genomic tests. Diagnostics that pair the right treatment with the right patient. For Healthy Lung Month, Johnson & Johnson researchers share the progress that’s being made to thwart the #1 cancer killer.

      How data science is ushering in a new era of modern medicine

      Algorithms, artificial intelligence, machine learning and other technologies are transforming the way physicians identify, treat and manage diseases. Here’s how Johnson & Johnson is putting the latest tools to work.

      Lung cancer requires a multidisciplinary approach

      Tackling Lung Cancer with Patients at the Center

      Additional oncology resources

      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.